Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?

This article compares two healthcare ETFs, Fidelity's FHLC and Invesco's RSPH, to help investors decide which is a better buy. FHLC offers lower costs, broader diversification with 365 holdings, and has historically shown stronger returns due to its market-cap-weighted approach. RSPH, while more expensive, provides an equal-weighted strategy across 60 S&P 500 healthcare stocks, appealing to those who wish to reduce dependence on mega-cap companies.